SARS-CoV-2 spike antibodies cross-react with dengue virus and enhance infection in vitro and in vivo
K. Jakhar, S. Sonar, G. Singh…·S. Mani
The paper shows that SARS-CoV-2 spike antibodies can enhance DENV2 infection in vitro and in vivo, suggesting potential for increased dengue severity in COVID-19 survivors.